A Non-Canonical Role for IRE1α Links ER and Mitochondria as Key Regulators of Astrocyte Dysfunction: Implications in Methamphetamine use and HIV-Associated Neurocognitive Disorders.

astrogliosis metabolic function mitochondria-associated ER membranes neurodegeneration neuroinflammation unfolded protein response

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2022
Historique:
received: 28 03 2022
accepted: 20 05 2022
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 6 7 2022
Statut: epublish

Résumé

Astrocytes are one of the most numerous glial cells in the central nervous system (CNS) and provide essential support to neurons to ensure CNS health and function. During a neuropathological challenge, such as during human immunodeficiency virus (HIV)-1 infection or (METH)amphetamine exposure, astrocytes shift their neuroprotective functions and can become neurotoxic. Identifying cellular and molecular mechanisms underlying astrocyte dysfunction are of heightened importance to optimize the coupling between astrocytes and neurons and ensure neuronal fitness against CNS pathology, including HIV-1-associated neurocognitive disorders (HAND) and METH use disorder. Mitochondria are essential organelles for regulating metabolic, antioxidant, and inflammatory profiles. Moreover, endoplasmic reticulum (ER)-associated signaling pathways, such as calcium and the unfolded protein response (UPR), are important messengers for cellular fate and function, including inflammation and mitochondrial homeostasis. Increasing evidence supports that the three arms of the UPR are involved in the direct contact and communication between ER and mitochondria through mitochondria-associated ER membranes (MAMs). The current study investigated the effects of HIV-1 infection and chronic METH exposure on astrocyte ER and mitochondrial homeostasis and then examined the three UPR messengers as potential regulators of astrocyte mitochondrial dysfunction. Using primary human astrocytes infected with pseudotyped HIV-1 or exposed to low doses of METH for 7 days, astrocytes had increased mitochondrial oxygen consumption rate (OCR), cytosolic calcium flux and protein expression of UPR mediators. Notably, inositol-requiring protein 1α (IRE1α) was most prominently upregulated following both HIV-1 infection and chronic METH exposure. Moreover, pharmacological inhibition of the three UPR arms highlighted IRE1α as a key regulator of astrocyte metabolic function. To further explore the regulatory role of astrocyte IRE1α, astrocytes were transfected with an IRE1α overexpression vector followed by activation with the proinflammatory cytokine interleukin 1β. Overall, our findings confirm IRE1α modulates astrocyte mitochondrial respiration, glycolytic function, morphological activation, inflammation, and glutamate uptake, highlighting a novel potential target for regulating astrocyte dysfunction. Finally, these findings suggest both canonical and non-canonical UPR mechanisms of astrocyte IRE1α. Thus, additional studies are needed to determine how to best balance astrocyte IRE1α functions to both promote astrocyte neuroprotective properties while preventing neurotoxic properties during CNS pathologies.

Identifiants

pubmed: 35784841
doi: 10.3389/fnins.2022.906651
pmc: PMC9247407
doi:

Types de publication

Journal Article

Langues

eng

Pagination

906651

Subventions

Organisme : NIDA NIH HHS
ID : F31 DA053151
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA039789
Pays : United States
Organisme : NICHD NIH HHS
ID : R24 HD000836
Pays : United States

Informations de copyright

Copyright © 2022 Proulx, Stacy, Park and Borgmann.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurochem. 2005 Oct;95(2):429-36
pubmed: 16086684
Brain Pathol. 1994 Jul;4(3):229-37
pubmed: 7952264
J Cell Sci. 2011 Jul 1;124(Pt 13):2143-52
pubmed: 21628424
Front Immunol. 2018 Nov 20;9:2633
pubmed: 30515154
Front Neurosci. 2015 Jan 12;8:445
pubmed: 25628526
Adv Exp Med Biol. 2017;997:13-31
pubmed: 28815519
J Infect Dis. 2003 Dec 15;188(12):1820-6
pubmed: 14673760
J Invest Dermatol. 2022 Jun;142(6):1682-1691.e7
pubmed: 34808241
Biomed Pharmacother. 1997;51(10):417-26
pubmed: 9863499
J Biol Phys. 2009 Oct;35(4):317-36
pubmed: 19669420
Front Neurosci. 2021 Oct 21;15:715945
pubmed: 34744606
Neurobiol Aging. 2021 Jul;103:68-77
pubmed: 33845398
AIDS. 2020 Jun 1;34(7):963-978
pubmed: 32379159
Sci Rep. 2020 Feb 27;10(1):3571
pubmed: 32107448
Cell Prolif. 2020 Mar;53(3):e12781
pubmed: 32035016
Glia. 2017 Feb;65(2):250-263
pubmed: 27761954
AIDS Res Hum Retroviruses. 2009 Nov;25(11):1117-21
pubmed: 19895343
J Neuroinflammation. 2011 Oct 25;8:145
pubmed: 22027397
Neurosci Lett. 2012 Nov 14;530(1):75-9
pubmed: 23022501
Neurochem Int. 2017 Oct;109:171-183
pubmed: 28389271
J Neurosci. 2001 Dec 1;21(23):9414-8
pubmed: 11717374
J Neuroinflammation. 2017 Mar 9;14(1):49
pubmed: 28279172
Mol Med Rep. 2017 May;15(5):3105-3110
pubmed: 28358434
Glia. 2019 May;67(5):802-824
pubmed: 30582668
Cells. 2020 May 08;9(5):
pubmed: 32397116
J Clin Invest. 2019 Jul 15;129(8):3339-3346
pubmed: 31305262
J Neurochem. 2013 May;125(4):566-74
pubmed: 23414433
Cell. 2019 Jan 24;176(3):581-596.e18
pubmed: 30661753
Front Neurol. 2020 Nov 25;11:593146
pubmed: 33324330
Exp Neurol. 2015 Jan;263:221-34
pubmed: 25246228
J Pharmacol Exp Ther. 2000 Mar;292(3):853-60
pubmed: 10688597
Cell Death Discov. 2017 Dec 04;3:17061
pubmed: 29354290
mBio. 2015 Jul 14;6(4):e00705
pubmed: 26173697
Neurotox Res. 2018 Feb;33(2):433-447
pubmed: 28993979
Front Cell Dev Biol. 2019 Aug 21;7:172
pubmed: 31497601
J Neurosci Methods. 2019 May 15;320:50-63
pubmed: 30904500
PLoS One. 2012;7(3):e33657
pubmed: 22438978
Neurotoxicol Teratol. 2001 Jul-Aug;23(4):349-54
pubmed: 11485837
Cell Metab. 2020 Apr 7;31(4):791-808.e8
pubmed: 32220306
Adv Neurobiol. 2014;11:13-30
pubmed: 25236722
Nat Cell Biol. 2019 Jun;21(6):755-767
pubmed: 31110288
Cell Death Dis. 2014 Apr 17;5:e1188
pubmed: 24743743
Life Sci. 2021 Jan 15;265:118740
pubmed: 33188833
J Biol Chem. 2018 Jan 5;293(1):296-311
pubmed: 29158267
Neurotox Res. 2017 Nov;32(4):723-733
pubmed: 28695547
Int Rev Neurobiol. 2019;145:29-65
pubmed: 31208526
Mol Cell. 2019 Jun 6;74(5):877-890.e6
pubmed: 31023583
FASEB J. 2017 Mar;31(3):864-867
pubmed: 28246299
Am J Pathol. 2013 Apr;182(4):1412-24
pubmed: 23395094
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2328-2337
pubmed: 30659145
J Immunol. 2021 Jul 1;207(1):210-220
pubmed: 34145058
J Cell Physiol. 2013 Sep;228(9):1802-18
pubmed: 23629871
Am J Pathol. 2008 Jun;172(6):1617-24
pubmed: 18458095
Int J Biochem Cell Biol. 2012 Jan;44(1):16-20
pubmed: 22064245
J Virol. 2018 Oct 29;92(22):
pubmed: 30158296
Cell Death Dis. 2013 Oct 10;4:e850
pubmed: 24113184
Curr HIV Res. 2012 Oct;10(7):557-71
pubmed: 22973853
Front Aging Neurosci. 2019 Mar 19;11:59
pubmed: 30941031
J Clin Microbiol. 2001 Apr;39(4):1303-10
pubmed: 11283046
Front Physiol. 2012 Jul 16;3:263
pubmed: 22934019
Birth Defects Res C Embryo Today. 2016 Jun;108(2):131-41
pubmed: 27297291
Exp Anim. 2018 Jul 30;67(3):373-382
pubmed: 29695649
J Neurovirol. 2015 Feb;21(1):66-80
pubmed: 25522787
Sci Rep. 2016 Jan 07;6:18929
pubmed: 26740125
J Neuroimmune Pharmacol. 2016 Sep;11(3):495-510
pubmed: 27484318
J Neuroinflammation. 2015 Feb 17;12:29
pubmed: 25889537
EMBO J. 2012 Nov 5;31(21):4106-23
pubmed: 22892566
PLoS One. 2013 Oct 18;8(10):e76941
pubmed: 24204710
Cell Rep. 2018 Mar 13;22(11):2827-2836
pubmed: 29539413
J Neurosci Res. 2006 May 15;83(7):1281-92
pubmed: 16555295
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7916-21
pubmed: 23620518
J Virol. 2001 Sep;75(17):7925-33
pubmed: 11483737
Nature. 2013 Jul 18;499(7458):295-300
pubmed: 23868258
Autophagy. 2018;14(9):1596-1619
pubmed: 29966509
J AIDS Clin Res. 2013 Nov 1;4(11):255
pubmed: 24587966
J Virol. 2020 Feb 28;94(6):
pubmed: 31896591
Int J Mol Sci. 2020 Aug 25;21(17):
pubmed: 32854418
J Neurosci Res. 2009 Aug 1;87(10):2326-39
pubmed: 19365854
Sci Transl Med. 2019 Feb 6;11(478):
pubmed: 30728287
Cell Death Dis. 2018 Feb 22;9(3):317
pubmed: 29472528
Cell Calcium. 2017 Mar;62:1-15
pubmed: 28108029
Acta Neuropathol Commun. 2018 Oct 1;6(1):102
pubmed: 30270816
J Neuroimmune Pharmacol. 2015 Sep;10(3):477-86
pubmed: 25850893
J Cell Sci. 2020 Aug 11;133(15):
pubmed: 32788208
J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S55-61
pubmed: 12394783
J Neuroinflammation. 2020 Sep 20;17(1):276
pubmed: 32951595
Neuropharmacology. 2017 May 1;117:364-375
pubmed: 28212984
Oncotarget. 2016 Jul 19;7(29):46100-46119
pubmed: 27323860
Front Neurosci. 2018 Jul 13;12:470
pubmed: 30057523
Cell Host Microbe. 2018 Nov 14;24(5):625-636.e5
pubmed: 30449314
J Extracell Vesicles. 2019 Dec 26;9(1):1706801
pubmed: 32002171
PLoS One. 2018 Jun 26;13(6):e0199861
pubmed: 29944719
Aging Dis. 2019 Jun 01;10(3):664-675
pubmed: 31165009
Cell Death Discov. 2018 Feb 2;4:8
pubmed: 29531805
Curr HIV Res. 2012 Jul;10(5):392-406
pubmed: 22591363
Cell Calcium. 2021 Jun;96:102383
pubmed: 33676316
Eur J Pharmacol. 2000 Jun 9;398(1):11-8
pubmed: 10856443
J Int Neuropsychol Soc. 2004 Jan;10(1):1-14
pubmed: 14751002
J Pharmacol Exp Ther. 2000 Mar;292(3):1042-7
pubmed: 10688621
Mol Neurobiol. 2017 Oct;54(8):6287-6303
pubmed: 27714635
Neurobiol Dis. 2019 Oct;130:104502
pubmed: 31238091
Neuropharmacology. 2014 Oct;85:499-507
pubmed: 24950453
AIDS. 2007 Jan 11;21(2):239-41
pubmed: 17197817
Hum Mol Genet. 2008 Jun 1;17(11):1517-26
pubmed: 18263603
Viruses. 2021 Nov 29;13(12):
pubmed: 34960656
Front Immunol. 2019 Aug 02;10:1789
pubmed: 31428093
Neuropsychopharmacology. 2015 Jul;40(8):1899-909
pubmed: 25652249
Biochem Soc Trans. 2016 Apr 15;44(2):499-504
pubmed: 27068961
Cell Death Dis. 2018 Mar 16;9(4):415
pubmed: 29549313
Mol Biol Cell. 2004 Nov;15(11):4818-28
pubmed: 15317844
Brain Res. 2019 Nov 1;1722:146389
pubmed: 31425679
Mol Neurobiol. 2016 Jan;53(1):132-142
pubmed: 25409632
Neurobiol Dis. 2016 Feb;86:154-69
pubmed: 26611103
Viruses. 2021 Sep 21;13(9):
pubmed: 34578464
Clin Immunol Immunopathol. 1989 Mar;50(3):374-84
pubmed: 2492910
Cell Death Dis. 2018 Feb 28;9(3):332
pubmed: 29491385
Ann N Y Acad Sci. 2008 Oct;1141:96-104
pubmed: 18991953
Trends Endocrinol Metab. 2014 Oct;25(10):528-37
pubmed: 25048297
J Biol Chem. 2016 Oct 21;291(43):22819-22829
pubmed: 27609520
Retrovirology. 2016 Aug 11;13(1):55
pubmed: 27515378
Cell Death Differ. 2012 Nov;19(11):1880-91
pubmed: 22705852
Front Microbiol. 2015 Oct 27;6:1143
pubmed: 26579077
Neurotox Res. 2016 May;29(4):583-593
pubmed: 26936603
Nat Immunol. 2019 Jul;20(7):865-878
pubmed: 31086333
PLoS Pathog. 2020 Jun 11;16(6):e1008381
pubmed: 32525948
Biomedicines. 2020 Nov 06;8(11):
pubmed: 33171974
J Cell Sci. 2009 May 15;122(Pt 10):1626-36
pubmed: 19420237
Cell Rep. 2021 Dec 21;37(12):110133
pubmed: 34936875

Auteurs

Jessica Proulx (J)

Department of Microbiology, Immunology and Genetics at University of North Texas Health Science Center, Fort Worth, TX, United States.

Satomi Stacy (S)

Department of Microbiology, Immunology and Genetics at University of North Texas Health Science Center, Fort Worth, TX, United States.

In-Woo Park (IW)

Department of Microbiology, Immunology and Genetics at University of North Texas Health Science Center, Fort Worth, TX, United States.

Kathleen Borgmann (K)

Department of Microbiology, Immunology and Genetics at University of North Texas Health Science Center, Fort Worth, TX, United States.

Classifications MeSH